The role of teicoplanin in the treatment of SARS-CoV-2 infection: a retrospective study in critically ill COVID-19 patients (Tei-COVID Study)
01 Pubblicazione su rivista
Ceccarelli Giancarlo, Alessandri Francesco, Oliva Alessandra, Borrazzo Cristian, Dell'Isola Serena, Ialungo Anna, Rastrelli Elena, Pelli Massimiliano, Raponi Giammarco, Turriziani Ombretta, Ruberto Franco, Rocco Monica, Pugliese Francesco, Russo Alessandro, d'Ettorre Gabriella, Venditti Mario
DOI: 10.1002/jmv.26925
ISSN: 0146-6615
Teicoplanin has a potential antiviral activity expressed against SARS-CoV-2 and was suggested as a complementary option to treat COVID-19 patients. In this multicentric, retrospective, observational research the aim was to evaluate the impact of teicoplanin on the course of COVID-19 in critically ill patients.